Trials / Unknown
UnknownNCT06259487
Coordinated Vaccination Against RSV and Influenza in Patients With Chronic Heart Failure and Its Impact on Prognosis.
Study on the Impact of Coordinated Immunizations Against RSV and Influenza on the Prognosis in Patients With Chronic Heart Failure.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Wroclaw Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective, single-centre, open-label, randomized study aims to determine whether coordinated care in administering protective vaccinations (against Respiratory Syncytial Virus (RSV) and influenza) impacts the prognosis of patients with chronic heart failure. The main question it aims to answer is: • Does coordinated care through vaccinations improve the prognosis of patients with chronic heart failure?
Detailed description
The study aims to determine whether coordinated care in the form of administering protective vaccinations affects the prognosis of patients with chronic heart failure. The study will involve analyzing epidemiological data for each participant, followed by randomization into two treatment paths: receiving vaccinations against Respiratory Syncytial Virus (RSV) and influenza provided by the research team (i.e., during cardiology visits) versus following standard recommendations for protective vaccinations (i.e., receiving vaccinations at vaccination points). All vaccinations will be administered using vaccines registered with the appropriate authorities and approved for use in the EU and Poland.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Coordinated Vaccination | Coordinated Vaccination against Respiratory Syncytial Virus (RSV) and influenza provided by the research team (i.e., during cardiology visits) |
| BEHAVIORAL | Following recommendations | Guidance on following the standard recommendations for protective vaccinations (i.e., receiving vaccinations at vaccination points). |
Timeline
- Start date
- 2023-09-15
- Primary completion
- 2024-06-30
- Completion
- 2024-07-30
- First posted
- 2024-02-14
- Last updated
- 2024-02-14
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT06259487. Inclusion in this directory is not an endorsement.